Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Diffuse Large B-Cell Lymphoma Refractory 1

Interventions

loncastuximab tesirine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Diffuse Large B-Cell Lymphoma Refractory × loncastuximab tesirine × Clear all
NCT03589469 2023-08-29

LOTIS-2

ADC Therapeutics S.A.

Phase 2 Completed
145 enrolled 24 charts 1 FDA
Lymphoid

Diffuse Large B-Cell Lymphoma Refractory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡